研发-话题@MedSci

#研发#

826篇内容 | 7112人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1300314, encodeId=7769130031490, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=前高管携大量研发机密跳槽辉瑞，后知后觉的默沙东能否跑赢这场疫苗大战？, objectType=article, longId=181181, objectId=131018118166, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=131018118166, replyNumber=0, likeNumber=0, createdTime=2019-10-16, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=131018118166, moduleTitle=前高管携大量研发机密跳槽辉瑞，后知后觉的默沙东能否跑赢这场疫苗大战？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=131018118166)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300313, encodeId=af6a13003134d, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=约2000万元，30位专家为一名患者研发专属药物，个性化医疗迈入新时代, objectType=article, longId=181180, objectId=1dc8181180e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1dc8181180e6, replyNumber=0, likeNumber=92, createdTime=2019-10-16, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1dc8181180e6, moduleTitle=约2000万元，30位专家为一名患者研发专属药物，个性化医疗迈入新时代, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1dc8181180e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300312, encodeId=8f881300312dd, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=2019 CSCO 大咖发声：国内自主研发抗肿瘤药物研发“全面开花”, objectType=article, longId=181179, objectId=d68a1811e971, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d68a1811e971, replyNumber=0, likeNumber=86, createdTime=2019-10-16, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d68a1811e971, moduleTitle=2019 CSCO 大咖发声：国内自主研发抗肿瘤药物研发“全面开花”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d68a1811e971)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300311, encodeId=3b371300311f7, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=全球20大药企全新榜单出炉，它们的近期研发进展你都知道吗？, objectType=article, longId=180937, objectId=980718093e77, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=980718093e77, replyNumber=0, likeNumber=64, createdTime=2019-10-12, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=980718093e77, moduleTitle=全球20大药企全新榜单出炉，它们的近期研发进展你都知道吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=980718093e77)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300310, encodeId=e49e130031079, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=开立医疗自主研发超声内窥镜完成临床实验并获欧盟CE认证, objectType=article, longId=180840, objectId=3c6618084097, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c6618084097, replyNumber=0, likeNumber=160, createdTime=2019-10-11, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c6618084097, moduleTitle=开立医疗自主研发超声内窥镜完成临床实验并获欧盟CE认证, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c6618084097)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300309, encodeId=f1d21300309ca, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=中国研发出上消化道肿瘤内镜AI辅助诊断系统，敏感性超九成, objectType=article, longId=180776, objectId=2864180e765c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2864180e765c, replyNumber=0, likeNumber=109, createdTime=2019-10-10, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2864180e765c, moduleTitle=中国研发出上消化道肿瘤内镜AI辅助诊断系统，敏感性超九成, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2864180e765c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300308, encodeId=52cf1300308b5, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=真实世界证据支持药物研发？ ——读真实世界证据支持药物研发征求意见稿的启示, objectType=article, longId=180747, objectId=9a2a180e47c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a2a180e47c8, replyNumber=0, likeNumber=91, createdTime=2019-10-10, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a2a180e47c8, moduleTitle=真实世界证据支持药物研发？ ——读真实世界证据支持药物研发征求意见稿的启示, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a2a180e47c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300307, encodeId=c381130030e17, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=2019 ESMO|从艾氟替尼数据发布看中国抗肿瘤新药研发盛况, objectType=article, longId=180452, objectId=78f31804521c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78f31804521c, replyNumber=0, likeNumber=56, createdTime=2019-10-05, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78f31804521c, moduleTitle=2019 ESMO|从艾氟替尼数据发布看中国抗肿瘤新药研发盛况, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=78f31804521c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300306, encodeId=9f2b130030692, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=研发客发布《2019中国生物医药产业发展蓝皮书》, objectType=article, longId=179640, objectId=b48f1e9640f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b48f1e9640f4, replyNumber=0, likeNumber=72, createdTime=2019-09-19, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b48f1e9640f4, moduleTitle=研发客发布《2019中国生物医药产业发展蓝皮书》, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b48f1e9640f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300305, encodeId=85e3130030508, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=阿尔茨海默症治疗再遇挫折：Eisai和Biogen终止了BACE抑制剂elenbecestat的研发, objectType=article, longId=179448, objectId=9f5b1e9448be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f5b1e9448be, replyNumber=0, likeNumber=44, createdTime=2019-09-16, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f5b1e9448be, moduleTitle=阿尔茨海默症治疗再遇挫折：Eisai和Biogen终止了BACE抑制剂elenbecestat的研发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f5b1e9448be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300304, encodeId=e6bc1300304f9, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=就差临门一脚？现在说AI药物研发时代到来还为时尚早, objectType=article, longId=179393, objectId=78841e939351, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78841e939351, replyNumber=0, likeNumber=57, createdTime=2019-09-15, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78841e939351, moduleTitle=就差临门一脚？现在说AI药物研发时代到来还为时尚早, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=78841e939351)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300303, encodeId=27b61300303ea, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=AI药物研发公司B轮融3700万美元，9月自然子刊发文, objectType=article, longId=179275, objectId=2a1d1e9275b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2a1d1e9275b6, replyNumber=0, likeNumber=102, createdTime=2019-09-12, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a1d1e9275b6, moduleTitle=AI药物研发公司B轮融3700万美元，9月自然子刊发文, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2a1d1e9275b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300302, encodeId=5a0b1300302cd, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=万泰生物联手GSK研发新一代宫颈癌疫苗：抗原技术来自中方, objectType=article, longId=179110, objectId=2d5c1e9110fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d5c1e9110fe, replyNumber=0, likeNumber=58, createdTime=2019-09-09, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d5c1e9110fe, moduleTitle=万泰生物联手GSK研发新一代宫颈癌疫苗：抗原技术来自中方, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2d5c1e9110fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300301, encodeId=c8f013003011a, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=突破！中国研究人员研发出修复牙釉质的新材料, objectType=article, longId=178643, objectId=e5e71e8643e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e5e71e8643e2, replyNumber=0, likeNumber=76, createdTime=2019-09-04, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e5e71e8643e2, moduleTitle=突破！中国研究人员研发出修复牙釉质的新材料, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e5e71e8643e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300300, encodeId=6daf1300300ba, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=AbbVie靶向癌症干细胞的ADC药物Rova-T治疗小细胞肺癌失败，宣布终止研发计划, objectType=article, longId=178544, objectId=d3591e85445f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3591e85445f, replyNumber=0, likeNumber=70, createdTime=2019-09-03, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3591e85445f, moduleTitle=AbbVie靶向癌症干细胞的ADC药物Rova-T治疗小细胞肺癌失败，宣布终止研发计划, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3591e85445f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300299, encodeId=8f9513002991a, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=金斯瑞2019年度中期业绩显示：四大业务稳健增长，研发投入持续加大, objectType=article, longId=178496, objectId=b0c61e8496b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b0c61e8496b4, replyNumber=0, likeNumber=57, createdTime=2019-09-02, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b0c61e8496b4, moduleTitle=金斯瑞2019年度中期业绩显示：四大业务稳健增长，研发投入持续加大, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b0c61e8496b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300298, encodeId=2c661300298de, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=共计34个，第三批鼓励研发申报儿童药品清单公布, objectType=article, longId=178371, objectId=27ec1e8371c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27ec1e8371c6, replyNumber=0, likeNumber=78, createdTime=2019-08-31, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27ec1e8371c6, moduleTitle=共计34个，第三批鼓励研发申报儿童药品清单公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=27ec1e8371c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300297, encodeId=a83b130029e0e, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=听老中青三代谈谈新药研发的故事, objectType=article, longId=178290, objectId=b6ef1e82905d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b6ef1e82905d, replyNumber=0, likeNumber=50, createdTime=2019-08-30, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6ef1e82905d, moduleTitle=听老中青三代谈谈新药研发的故事, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b6ef1e82905d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300296, encodeId=e2a91300296d8, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=阿斯利康9500万美元购买优先审评券，哪项研发项目可能获益？, objectType=article, longId=178193, objectId=79801e81931e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=79801e81931e, replyNumber=0, likeNumber=60, createdTime=2019-08-27, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=79801e81931e, moduleTitle=阿斯利康9500万美元购买优先审评券，哪项研发项目可能获益？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=79801e81931e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300295, encodeId=8db913002955b, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=落户珠海高科技产业园普米斯珠海研发中心隆重开业, objectType=article, longId=177586, objectId=4a4c1e7586a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a4c1e7586a9, replyNumber=0, likeNumber=51, createdTime=2019-08-15, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a4c1e7586a9, moduleTitle=落户珠海高科技产业园普米斯珠海研发中心隆重开业, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4a4c1e7586a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

研发

2020-05-29

lqvr (审核中...)

前往app查看评论内容

#研发#

前高管携大量研发机密跳槽辉瑞，后知后觉的默沙东能否跑赢这场疫苗大战？

2019-10-16

lqvr (审核中...)

前往app查看评论内容

#研发#

约2000万元，30位专家为一名患者研发专属药物，个性化医疗迈入新时代

2019-10-16

lqvr (审核中...)

前往app查看评论内容

#研发#

2019 CSCO 大咖发声：国内自主研发抗肿瘤药物研发“全面开花”

2019-10-16

lqvr (审核中...)

前往app查看评论内容

#研发#

全球20大药企全新榜单出炉，它们的近期研发进展你都知道吗？

2019-10-12

lqvr (审核中...)

前往app查看评论内容

#研发#

开立医疗自主研发超声内窥镜完成临床实验并获欧盟CE认证

2019-10-11

lqvr (审核中...)

前往app查看评论内容

#研发#

中国研发出上消化道肿瘤内镜AI辅助诊断系统，敏感性超九成

2019-10-10

lqvr (审核中...)

前往app查看评论内容

#研发#

真实世界证据支持药物研发？ ——读真实世界证据支持药物研发征求意见稿的启示

2019-10-10

lqvr (审核中...)

前往app查看评论内容

#研发#

2019 ESMO|从艾氟替尼数据发布看中国抗肿瘤新药研发盛况

2019-10-05

lqvr (审核中...)

前往app查看评论内容

#研发#

研发客发布《2019中国生物医药产业发展蓝皮书》

2019-09-19

lqvr (审核中...)

前往app查看评论内容

#研发#

阿尔茨海默症治疗再遇挫折：Eisai和Biogen终止了BACE抑制剂elenbecestat的研发

2019-09-16

lqvr (审核中...)

前往app查看评论内容

#研发#

就差临门一脚？现在说AI药物研发时代到来还为时尚早

2019-09-15

lqvr (审核中...)

前往app查看评论内容

#研发#

AI药物研发公司B轮融3700万美元，9月自然子刊发文

2019-09-12

lqvr (审核中...)

前往app查看评论内容

#研发#

万泰生物联手GSK研发新一代宫颈癌疫苗：抗原技术来自中方

2019-09-09

lqvr (审核中...)

前往app查看评论内容

#研发#

突破！中国研究人员研发出修复牙釉质的新材料

2019-09-04

lqvr (审核中...)

前往app查看评论内容

#研发#

AbbVie靶向癌症干细胞的ADC药物Rova-T治疗小细胞肺癌失败，宣布终止研发计划

2019-09-03

lqvr (审核中...)

前往app查看评论内容

#研发#

金斯瑞2019年度中期业绩显示：四大业务稳健增长，研发投入持续加大

2019-09-02

lqvr (审核中...)

前往app查看评论内容

#研发#

共计34个，第三批鼓励研发申报儿童药品清单公布

2019-08-31

lqvr (审核中...)

前往app查看评论内容

#研发#

听老中青三代谈谈新药研发的故事

2019-08-30

lqvr (审核中...)

前往app查看评论内容

#研发#

阿斯利康9500万美元购买优先审评券，哪项研发项目可能获益？

2019-08-27

lqvr (审核中...)

前往app查看评论内容

#研发#

落户珠海高科技产业园普米斯珠海研发中心隆重开业

2019-08-15

科室
- - 订阅+
  - 更多科室
工具
服务